Omeros Corp. buy melinda
Start price
14.11.18
/
50%
€10.54
Target price
28.11.18
€23.99
Performance (%)
20.03%
End price
28.11.18
€12.65
Summary
This prediction ended on 28.11.18 with a price of €12.65. The prediction had a final performance of 20.03%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Omeros Corp. | 13.467% | 13.467% | 197.968% | 68.081% |
| iShares Core DAX® | 4.572% | 3.428% | 8.167% | 58.377% |
| iShares Nasdaq 100 | 1.832% | -1.036% | 34.659% | 87.702% |
| iShares Nikkei 225® | -0.289% | 3.380% | 61.852% | 78.201% |
| iShares S&P 500 | 2.229% | 0.472% | 25.073% | 65.682% |
Comments by melinda for this prediction
In the thread Omeros Corp. diskutieren
SecteurRecherche biotechnologique et médicale Agenda 25/03 Publication de résultats
Omeros Corp. Gregory A. Société
créée en2003.Gregor A. Demopulos et Pamela Pierce Palmer, 16 juin 1994, ont leur siège à Seattle, WA.
Nombre d'employés : 173 personnes.
(Vom Mitglied beendet)